Literature DB >> 25533202

The HLA-DRβ1 amino acid positions 11-13-26 explain the majority of SLE-MHC associations.

Kwangwoo Kim1, So-Young Bang2, Hye-Soon Lee2, Yukinori Okada3, Buhm Han4, Woei-Yuh Saw5, Yik-Ying Teo6, Sang-Cheol Bae2.   

Abstract

Genetic association of the major histocompatibility complex (MHC) locus is well established in systemic lupus erythematosus (SLE), but the causal functional variants in this region have not yet been discovered. Here we conduct the first fine-mapping study, which thoroughly investigates the SLE-MHC associations down to the amino acid level of major HLA genes in 5,342 unrelated Korean case-control subjects, taking advantages of HLA imputation with a newly constructed Asian HLA reference panel. The most significant association is mapped to amino acid position 13 of HLA-DRβ1 (P=2.48 × 10(-17)) and its proxy position 11 (P=4.15 × 10(-17)), followed by position 26 in a stepwise conditional analysis (P=2.42 × 10(-9)). Haplotypes defined by amino acid positions 11-13-26 support the reported effects of most classical HLA-DRB1 alleles in Asian and European populations. In conclusion, our study identifies the three amino acid positions at the epitope-binding groove of HLA-DRβ1 that are responsible for most of the association between SLE and MHC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25533202     DOI: 10.1038/ncomms6902

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  36 in total

1.  The susceptible HLA class II alleles and their presenting epitope(s) in Goodpasture's disease.

Authors:  Li-Jun Xie; Zhao Cui; Fang-Jin Chen; Zhi-Yong Pei; Shui-Yi Hu; Qiu-Hua Gu; Xiao-Yu Jia; Li Zhu; Xu-Jie Zhou; Hong Zhang; Yun-Hua Liao; Lu-Hua Lai; Billy G Hudson; Ming-Hui Zhao
Journal:  Immunology       Date:  2017-05-16       Impact factor: 7.397

2.  Association Analysis of the MHC in Lupus Nephritis.

Authors:  Ricong Xu; Qibin Li; Rongjun Liu; Juan Shen; Ming Li; Minghui Zhao; Meng Wang; Qijun Liao; Haiping Mao; Zhijian Li; Na Zhou; Peiran Yin; Yue Li; Xueqing Tang; Tian Wu; Zhong Zhong; Yan Wang; Zhen Ai; Ou Wang; Nan Chen; Xiaoqin Yang; Junbin Fang; Ping Fu; Jieruo Gu; Kun Ye; Jian Chen; Lie Dai; Huafeng Liu; Zhangsuo Liu; Yunhua Liao; Jianxin Wan; Guohua Ding; Jinghong Zhao; Hao Zhang; Shuxia Fu; Liangdan Sun; Xuejun Zhang; Huanming Yang; Jian Wang; Jun Wang; Jianjun Liu; Yingrui Li; Xueqing Yu
Journal:  J Am Soc Nephrol       Date:  2017-07-28       Impact factor: 10.121

Review 3.  Moving towards a molecular taxonomy of autoimmune rheumatic diseases.

Authors:  Guillermo Barturen; Lorenzo Beretta; Ricard Cervera; Ronald Van Vollenhoven; Marta E Alarcón-Riquelme
Journal:  Nat Rev Rheumatol       Date:  2018-01-24       Impact factor: 20.543

Review 4.  The role of common protective alleles HLA-DRB1*13 among systemic autoimmune diseases.

Authors:  H Furukawa; S Oka; N Tsuchiya; K Shimada; A Hashimoto; S Tohma; A Kawasaki
Journal:  Genes Immun       Date:  2016-11-10       Impact factor: 2.676

5.  MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy.

Authors:  Zhao Cui; Li-Jun Xie; Fang-Jin Chen; Zhi-Yong Pei; Li-Jie Zhang; Zhen Qu; Jing Huang; Qiu-Hua Gu; Yi-Miao Zhang; Xin Wang; Fang Wang; Li-Qiang Meng; Gang Liu; Xu-Jie Zhou; Li Zhu; Ji-Cheng Lv; Fan Liu; Hong Zhang; Yun-Hua Liao; Lu-Hua Lai; Pierre Ronco; Ming-Hui Zhao
Journal:  J Am Soc Nephrol       Date:  2016-11-16       Impact factor: 10.121

6.  Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk.

Authors:  Jennie G Pouget; Buhm Han; Yang Wu; Emmanuel Mignot; Hanna M Ollila; Jonathan Barker; Sarah Spain; Nick Dand; Richard Trembath; Javier Martin; Maureen D Mayes; Lara Bossini-Castillo; Elena López-Isac; Ying Jin; Stephanie A Santorico; Richard A Spritz; Hakon Hakonarson; Constantin Polychronakos; Soumya Raychaudhuri; Jo Knight
Journal:  Hum Mol Genet       Date:  2019-10-15       Impact factor: 6.150

7.  Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity.

Authors:  Prithvi Raj; Ekta Rai; Ran Song; Shaheen Khan; Benjamin E Wakeland; Kasthuribai Viswanathan; Carlos Arana; Chaoying Liang; Bo Zhang; Igor Dozmorov; Ferdicia Carr-Johnson; Mitja Mitrovic; Graham B Wiley; Jennifer A Kelly; Bernard R Lauwerys; Nancy J Olsen; Chris Cotsapas; Christine K Garcia; Carol A Wise; John B Harley; Swapan K Nath; Judith A James; Chaim O Jacob; Betty P Tsao; Chandrashekhar Pasare; David R Karp; Quan Zhen Li; Patrick M Gaffney; Edward K Wakeland
Journal:  Elife       Date:  2016-02-15       Impact factor: 8.140

Review 8.  New Developments in the Genetics of Inclusion Body Myositis.

Authors:  Kyla A Britson; Stephanie Y Yang; Thomas E Lloyd
Journal:  Curr Rheumatol Rep       Date:  2018-04-02       Impact factor: 4.592

Review 9.  The dynamic evolution of rheumatology in Korea.

Authors:  Ho-Youn Kim; Yeong-Wook Song
Journal:  Nat Rev Rheumatol       Date:  2015-12-17       Impact factor: 20.543

10.  Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans.

Authors:  Christopher J Lessard; Satria Sajuthi; Jian Zhao; Kwangwoo Kim; John A Ice; He Li; Hannah Ainsworth; Astrid Rasmussen; Jennifer A Kelly; Mindy Marion; So-Young Bang; Young Bin Joo; Jeongim Choi; Hye-Soon Lee; Young Mo Kang; Chang-Hee Suh; Won Tae Chung; Soo-Kon Lee; Jung-Yoon Choe; Seung Cheol Shim; Ji Hee Oh; Young Jin Kim; Bok-Ghee Han; Nan Shen; Hwee Siew Howe; Edward K Wakeland; Quan-Zhen Li; Yeong Wook Song; Patrick M Gaffney; Marta E Alarcón-Riquelme; Lindsey A Criswell; Chaim O Jacob; Robert P Kimberly; Timothy J Vyse; John B Harley; Kathy L Sivils; Sang-Cheol Bae; Carl D Langefeld; Betty P Tsao
Journal:  Arthritis Rheumatol       Date:  2016-05       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.